Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 11270942)

1.

Development of oseltamivir phosphonate congeners as anti-influenza agents.

Cheng TJ, Weinheimer S, Tarbet EB, Jan JT, Cheng YS, Shie JJ, Chen CL, Chen CA, Hsieh WC, Huang PW, Lin WH, Wang SY, Fang JM, Hu OY, Wong CH.

J Med Chem. 2012 Oct 25;55(20):8657-70. doi: 10.1021/jm3008486. Epub 2012 Oct 12.

2.

Optimal design of intervention studies to prevent influenza in healthy cohorts.

Klick B, Nishiura H, Cowling BJ.

PLoS One. 2012;7(4):e35166. doi: 10.1371/journal.pone.0035166. Epub 2012 Apr 13.

3.

The national pandemic flu service, oseltamivir, and a case of pancreatitis.

Newton R, King D, Lee H, Anderson M, Lynn J.

BMJ Case Rep. 2010;2010. pii: bcr11.2009.2439. doi: 10.1136/bcr.11.2009.2439. Epub 2010 Apr 9.

4.

Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom.

Pebody RG, Harris R, Kafatos G, Chamberland M, Campbell C, Nguyen-Van-Tam JS, McLean E, Andrews N, White PJ, Wynne-Evans E, Green J, Ellis J, Wreghitt T, Bracebridge S, Ihekweazu C, Oliver I, Smith G, Hawkins C, Salmon R, Smyth B, McMenamin J, Zambon M, Phin N, Watson JM.

Emerg Infect Dis. 2011 Jun;17(6):990-9. doi: 10.3201/eid/1706.101161.

5.

Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.

Govorkova EA, Marathe BM, Prevost A, Rehg JE, Webster RG.

Antiviral Res. 2011 Aug;91(2):81-8. doi: 10.1016/j.antiviral.2011.05.008. Epub 2011 May 27.

6.

Oseltamivir (tamiflu) induced depressive episode in a female adolescent.

Chung S, Joung YS.

Psychiatry Investig. 2010 Dec;7(4):302-4. doi: 10.4306/pi.2010.7.4.302. Epub 2010 Nov 11.

7.

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.

Goldstein E, Cowling BJ, O'Hagan JJ, Danon L, Fang VJ, Hagy A, Miller JC, Reshef D, Robins J, Biedrzycki P, Lipsitch M.

BMC Infect Dis. 2010 Jul 20;10:211. doi: 10.1186/1471-2334-10-211.

8.

Pandemic preparedness in Hawaii: a multicenter verification of real-time RT-PCR for the direct detection of influenza virus types A and B.

Whelen AC, Bankowski MJ, Furuya G, Honda S, Ueki R, Chan A, Higa K, Kumashiro D, Moore N, Lee R, Koyamatsu T, Effler PV.

Public Health Rep. 2010 May-Jun;125 Suppl 2:81-7.

9.

Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic.

Goldstein E, Miller JC, O'Hagan JJ, Lipsitch M.

Influenza Other Respir Viruses. 2010 Mar;4(2):101-12. doi: 10.1111/j.1750-2659.2009.00128.x.

10.

Antiviral usage for H1N1 treatment: pros, cons and an argument for broader prescribing guidelines in the United States.

Goldstein E, Lipsitch M.

Version 2. PLoS Curr. 2009 Oct 29 [revised 2009 Nov 11];1:RRN1122.

11.

Predispensing of antivirals to high-risk individuals in an influenza pandemic.

Goldstein E, Miller JC, O'Hagan J, Lipsitch M.

Version 8. PLoS Curr. 2009 Aug 21 [revised 2009 Nov 12];1:RRN1007.

12.

Cost-benefit of stockpiling drugs for influenza pandemic.

Balicer RD, Huerta M, Davidovitch N, Grotto I.

Emerg Infect Dis. 2005 Aug;11(8):1280-2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk